1-20 of 132
Andrew L. Feldman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-world impact of differences in the WHO and ICC classifications of non-Hodgkin lymphoma: a LEO cohort study analysis

Brooj Abro, Matthew J. Maurer, Thomas M. Habermann, W. Richard Burack, Jennifer R. Chapman, Jonathon B. Cohen, Jonathan W. Friedberg, Giorgio Inghirami, Brad S. Kahl, Melissa C. Larson, Brian K. Link, Izidore S. Lossos, Peter Martin, Timothy J. McDonnell, Loretta J. Nastoupil, Shaun M. Riska, Sergei Syrbu, Francisco Vega, Kiran R. Vij, Christopher R. Flowers, James R. Cerhan, David L. Jaye, Andrew L. Feldman
Journal: Blood
Blood (2024) 144 (19): 2063–2066.
https://doi.org/10.1182/blood.2024025681
Published: 2024
Includes: Supplemental data
Journal Articles

Motive and opportunity: MYC rearrangements in high-grade B-cell lymphoma with MYC and BCL2 rearrangements (an LLMPP study)

Laura K. Hilton, Brett Collinge, Susana Ben-Neriah, Waleed Alduaij, Haya Shaalan, Andrew P. Weng, Manuela Cruz, Graham W. Slack, Pedro Farinha, Tomoko Miyata-Takata, Merrill Boyle, Barbara Meissner, James R. Cook, Sarah L. Ondrejka, German Ott, Andreas Rosenwald, Elias Campo, Catalina Amador, Timothy C. Greiner, Philipp W. Raess, Joo Y. Song, Giorgio Inghirami, Elaine S. Jaffe, Dennis D. Weisenburger, Wing C. Chan, Klaus Beiske, Kai Fu, Jan Delabie, Stefania Pittaluga, Javeed Iqbal, George Wright, Laurie H. Sehn, Kerry J. Savage, Andrew J. Mungall, Andrew L. Feldman, Louis M. Staudt, Christian Steidl, Lisa M. Rimsza, Ryan D. Morin, David W. Scott
Journal: Blood
Blood (2024) 144 (5): 525–540.
https://doi.org/10.1182/blood.2024024251
Published: 2024
Includes: Supplemental data
Journal Articles

Herpetic lymphadenitis mimicking Richter transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma

Samuel Bidot, Andrew L. Feldman
Journal: Blood
Blood (2024) 143 (26): 2808.
https://doi.org/10.1182/blood.2024024564
Published: 2024
Journal Articles

Occult ALK-negative anaplastic large cell lymphoma complicating chronic lymphocytic leukemia

Reham Ahmed, Andrew L. Feldman
Journal: Blood
Blood (2024) 143 (10): 938.
https://doi.org/10.1182/blood.2023022971
Published: 2024
Journal Articles

Cumulative Incidence, Predictors, and Outcomes of Transformation to Diffuse Large B-Cell Lymphoma in a Prospective Cohort of Patients with Marginal Zone Lymphoma

Côme Bommier, Brian K. Link, Brianna Gysbers, Matthew J. Maurer, Melissa C. Larson, Arushi Khurana, Yucai Wang, Carrie Thompson, Dai Chihara, Juan Pablo Alderuccio, Jean L. Koff, Izidore S. Lossos, Grzegorz S. Nowakowski, Andrew L. Feldman, Thomas M. Habermann, Rebecca L. King, James R. Cerhan
Journal: Blood
Blood (2023) 142 (Supplement 1): 1672.
https://doi.org/10.1182/blood-2023-186626
Published: 2023
Journal Articles

PET/CT Enables Appropriate Staging in Extranodal Marginal Zone Lymphoma

Juan Pablo Alderuccio, Michele D. Stanchina, Jean L. Koff, Isildinha M. Reis, Eduardo Edelman Saul, Melissa C. Larson, Dai Chihara, Wei Zhao, Thomas M. Habermann, Peter Martin, Loretta J. Nastoupil, Jennifer R. Chapman-Fredricks, Andrew L. Feldman, Brian K. Link, Brad S. Kahl, Jonathon B. Cohen, Mark K Polar, Rafael Henneman Sassi, Craig H. Moskowitz, Jonathan W. Friedberg, James R. Cerhan, Russ Kuker, Christopher R. Flowers, Izidore S. Lossos
Journal: Blood
Blood (2023) 142 (Supplement 1): 5134.
https://doi.org/10.1182/blood-2023-179478
Published: 2023
Journal Articles

Real-World Impact of Differences in the World Health Organization (WHO) Classification and International Consensus Classification (ICC) Systems on the Diagnosis of Non-Hodgkin Lymphoma: An Analysis from the LEO Cohort Study

Brooj Abro, Matthew J. Maurer, Thomas M. Habermann, Richard Burack, Jennifer R. Chapman-Fredricks, Jonathon B. Cohen, Jonathan W. Friedberg, Giorgio Inghirami, Brad S. Kahl, Melissa C. Larson, Brian K. Link, Izidore S. Lossos, Peter Martin, Timothy J. McDonnell, Loretta J. Nastoupil, Shaun M. Riska, Sergei Syrbu, Francisco Vega, Kiran R. Vij, Christopher R. Flowers, James R. Cerhan, David L Jaye, Andrew L. Feldman
Journal: Blood
Blood (2023) 142 (Supplement 1): 3708.
https://doi.org/10.1182/blood-2023-179303
Published: 2023
Journal Articles

Gene Expression Profiling Reveals Two Overarching Types of Anaplastic Large Cell Lymphoma with Distinct Targetable Biology: An L.L.M.P.P. Study

Andrew L. Feldman, Surendra Dasari, Lisa M. Rimsza, David W. Scott, Naoki Oishi, Catalina Amador, Elias Campo, Wing C. Chan, James R. Cook, Jan Delabie, Pedro Farinha, Kai Fu, Timothy C. Greiner, Giorgio Inghirami, Javeed Iqbal, Elaine S. Jaffe, Sarah L. Ondrejka, German Ott, Stefania Pittaluga, Phil Raess, Andreas Rosenwald, Kerry J. Savage, Graham Slack, Susan L. Slager, Joo Y. Song, Louis M. Staudt, George Wright, Hao-Wei Wang, Yu Zeng, Tadashi Yoshino, Xiaojun Wu, Ryan A. Wilcox, Xueju Wang, Akira Satou, Anamarija M. Perry, Roberto Miranda, L. Jeffrey Medeiros, Matthew J. Maurer, Eric Mou, Young Hyeh Ko, Kennosuke Karube, Brad S. Kahl, Liuyan Jiang, David L Jaye, Laurence de Leval, Weina Chen, Jennifer R. Chapman-Fredricks, James R. Cerhan, Carlos Barrionuevo, Stephen M Ansell, Ahmed Aljudi
Journal: Blood
Blood (2023) 142 (Supplement 1): 847.
https://doi.org/10.1182/blood-2023-186969
Published: 2023
Journal Articles

Impact of Frontline Treatment Strategy on Quality of Life in the First Decade after a Diagnosis of Marginal Zone Lymphoma

Côme Bommier, Mazie Tsang, Brie N. Noble, Carrie Thompson, Christopher Strouse, Carla Casulo, Eric Mou, Melissa C. Larson, Brianna Gysbers, Allison C. Rosenthal, Andrew L. Feldman, Matthew J. Maurer, Kathleen Yost, Susan L. Slager, Brian K. Link, Thomas M. Habermann, Amylou Constance Dueck, James R. Cerhan
Journal: Blood
Blood (2023) 142 (Supplement 1): 2394.
https://doi.org/10.1182/blood-2023-186862
Published: 2023
Journal Articles

Integrative Genomic and Transcriptomic Analysis Reveals Targetable Vulnerabilities in Angioimmunoblastic T-Cell Lymphoma

Alyssa Bouska, Weiwei Zhang, Sunandini Sharma, Harald Holte, Ab Rauf Shah, Waseem Gul Lone, Luca Vincenzo Cappelli, Danilo Fiore, Qiang Gong, Tayla Heavican-Foral, Jeffrey Cannatella, Catalina Amador, Aiza Arif, Lynette Smith, Soon Thye Lim, Choon Kiat Ong, Andrew L. Feldman, Ming-Qing Du, Laurence de Leval, Timothy C. Greiner, Kai Fu, Gunhild Trøen, Daniel Vodak, Sigve Nakken, Jan Delabie, David M. Weinstock, Stefano A. Pileri, Antonella Laginestra, Kyeongjin Kim, Utpal Pajvani, Julie M. Vose, Dennis D Weisenburger, Sandeep Dave, Giorgio Inghirami, Wing C. Chan, Javeed Iqbal
Journal: Blood
Blood (2023) 142 (Supplement 1): 2993.
https://doi.org/10.1182/blood-2023-186530
Published: 2023
Journal Articles

Lymphoid Malignancy Risk with Rare Inherited Variants in Known Cancer Predisposition Genes

Nicholas J. Boddicker, Raphael Mwangi, Dennis P. Robinson, Cristine Allmer, Allison C. Rosenthal, Thomas M. Habermann, Andrew L. Feldman, Lisa M. Rimsza, Rebecca King, Melissa C. Larson, Brianna Gysbers, Aaron D. Norman, Stephen M Ansell, Angela Dispenzieri, David L Murray, S. Vincent Rajkumar, Shaji Kunnathu Kumar, Jithma Prasad Abeykoon, Grzegorz S. Nowakowski, Thomas E. Witzig, Anne J. Novak, Celine M. Vachon, Susan L. Slager, James R. Cerhan
Journal: Blood
Blood (2023) 142 (Supplement 1): 2990.
https://doi.org/10.1182/blood-2023-182266
Published: 2023
Journal Articles

Diagnosis to Treatment Interval (DTI) Informs Outcomes across Subtypes of Aggressive B-Cell Lymphoma

Matthew J. Maurer, Arushi Khurana, Raphael Mwangi, Grzegorz S. Nowakowski, Carla Casulo, Dai Chihara, Jonathon B. Cohen, Brad S. Kahl, Izidore S. Lossos, Peter Martin, Yucai Wang, Timothy J. McDonnell, Andrew L. Feldman, David L Jaye, Thomas M. Habermann, James R. Cerhan, Christopher R. Flowers, Brian K. Link, Loretta J. Nastoupil
Journal: Blood
Blood (2023) 142 (Supplement 1): 3123.
https://doi.org/10.1182/blood-2023-174715
Published: 2023
Journal Articles

The FLIPI24 Prognostic Model Identifies Poor Outcomes in Non-Immunochemotherapy Treated Patients with Follicular Lymphoma

Carla Casulo, Melissa C. Larson, Christopher R. Flowers, Thomas M. Habermann, Thomas E. Witzig, Yucai Wang, Grzegorz S. Nowakowski, Andrew L. Feldman, Loretta J. Nastoupil, Dai Chihara, Richard Burack, Jonathan R Day, Urshila Durani, Peter Martin, Jonathon B. Cohen, Jonathan W. Friedberg, Izidore S. Lossos, Brad S. Kahl, Brian K. Link, James R. Cerhan, Matthew J. Maurer
Journal: Blood
Blood (2023) 142 (Supplement 1): 1657.
https://doi.org/10.1182/blood-2023-186684
Published: 2023
Journal Articles

Lymphoma-Related Quality of Life (QOL) Is Not Impacted By Initial Treatment Choice in Patients with Marginal Zone Lymphoma (MZL): Results from the Prospective Lymphoma Epidemiology of Outcomes (LEO) Cohort

Côme Bommier, Mazie Tsang, Brie N. Noble, Carrie Thompson, Carla Casulo, Michelle Hildebrandt, Allison C. Rosenthal, Eric Mou, Urshila Durani, Annalynn M Williams, Kathleen Yost, Melissa C. Larson, Brianna Gysbers, Matthew J. Maurer, Andrew L. Feldman, David L Jaye, Peter Martin, Jonathon B. Cohen, Dai Chihara, Izidore S. Lossos, Christopher Strouse, Brad S. Kahl, Thomas M. Habermann, Christopher R. Flowers, Amylou Constance Dueck, James R. Cerhan
Journal: Blood
Blood (2023) 142 (Supplement 1): 2395.
https://doi.org/10.1182/blood-2023-187056
Published: 2023
Journal Articles

Patterns of Care and Impact of Initial Treatment in Peripheral T-Cell Lymphoma: Outcome Analysis from the Lymphoma Epidemiology of Outcomes (LEO) and Molecular Epidemiology Resource (MER) Prospective Cohort Study

Jia Ruan, Zhengming Chen, Melissa C. Larson, N. Nora Bennani, Danielle Wallace, Pamela B. Allen, David L Jaye, Jonathon B. Cohen, Luis Enrique Malpica Castillo, Francisco Vega, Giorgio Inghirami, Eric Mou, Carla Casulo, Neha Mehta-Shah, Peter Martin, Matthew J. Maurer, Brad S. Kahl, Izidore S. Lossos, James R. Cerhan, Christopher R. Flowers, Andrew L. Feldman
Journal: Blood
Blood (2023) 142 (Supplement 1): 3079.
https://doi.org/10.1182/blood-2023-180318
Published: 2023
Journal Articles

Comparing Clinical Characteristics and Outcomes of MYC and BCL6 Double Hit Lymphoma (DHL- BCL6 ) with Other Aggressive B-Cell Lymphomas: Understanding the Impact of New Who and International Consensus Classifications

Arushi Khurana, Raphael Mwangi, James R. Cerhan, Jonathon B. Cohen, Jennifer R. Chapman-Fredricks, Jonathan W. Friedberg, Christopher R. Flowers, Richard Burack, Izidore S. Lossos, Loretta J. Nastoupil, Andrew L. Feldman, Brad S. Kahl, Peter Martin, Grzegorz S. Nowakowski, Brian K. Link, Timothy J. McDonnell, Giorgio Inghirami, Sergei Syrbu, Kiran R. Vij, Matthew J. Maurer, Thomas M. Habermann, Rebecca L. King
Journal: Blood
Blood (2023) 142 (Supplement 1): 67.
https://doi.org/10.1182/blood-2023-190316
Published: 2023
Journal Articles

The Presence of Bulky Disease and/or Very High LDH Defines a High-Risk Subset of IPI 1-2 for Eligibility in Clinical Trials of Newly Diagnosed Aggressive B-Cell Lymphoma

Matthew J. Maurer, Arushi Khurana, Umar Farooq, Jason T. Romancik, Jonathan W. Friedberg, Izidore S. Lossos, Brad S. Kahl, Peter Martin, Dai Chihara, Andrew L. Feldman, Sergei Syrbu, David L Jaye, Elliot Cahn, Thomas M. Habermann, Brian K. Link, James R. Cerhan, Christopher R. Flowers, Loretta J. Nastoupil, Grzegorz S. Nowakowski
Journal: Blood
Blood (2023) 142 (Supplement 1): 4512.
https://doi.org/10.1182/blood-2023-187350
Published: 2023
Journal Articles

Frontline Management Strategy and Quality of Life in Follicular Lymphoma: A Multi-Institutional Prospective Cohort Study

Mazie Tsang, Brie N. Noble, Côme Bommier, Carla Casulo, Carrie Thompson, Allison C. Rosenthal, Dai Chihara, Eric Mou, Urshila Durani, Annalynn M Williams, Michelle Hildebrandt, Kathleen Yost, Melissa C. Larson, Brianna Gysbers, Matthew J. Maurer, Susan L. Slager, Andrew L. Feldman, David L Jaye, Jon Tilburt, J. C. C. Villasboas, Ajay Major, Priyanka A Pophali, Talal Hilal, Yucai Wang, Timothy G. Call, Amber Koehler, Javier L. Munoz, Gita Thanarajasingam, Paul J Hampel, Sameer A. Parikh, Loretta J. Nastoupil, Thomas E. Witzig, Grzegorz S. Nowakowski, Stephen M Ansell, Jonathon B. Cohen, Thomas M. Habermann, Christopher Strouse, Izidore S. Lossos, Brad S. Kahl, Peter Martin, Christopher R. Flowers, James R. Cerhan, Amylou Constance Dueck
Journal: Blood
Blood (2023) 142 (Supplement 1): 3761.
https://doi.org/10.1182/blood-2023-188382
Published: 2023
Journal Articles

Refining Diagnostic Subtypes of Peripheral T-Cell Lymphoma Using a Multiparameter Approach

Catalina Amador, Dennis D Weisenburger, Ana Gomez, Alyssa Bouska, Francisco Vega, James R. Cook, Timothy C. Greiner, Andrew L. Feldman, Elaine S. Jaffe, Sarah L. Ondrejka, German Ott, Neval Ozkaya, Phil Raess, Andreas Rosenwald, Kerry J. Savage, Graham Slack, Joo Y. Song, Lisa M. Rimsza, Wing C. Chan, Javeed Iqbal
Journal: Blood
Blood (2023) 142 (Supplement 1): 1636.
https://doi.org/10.1182/blood-2023-186950
Published: 2023
Journal Articles

Tumor Mutational Burden As a Prognostic Factor in Diffuse Large B-Cell Lymphoma

Rosalie Griffin, Kerstin Wenzl, Vivekananda Sarangi, Lisa M. Rimsza, Rebecca King, Andrew L. Feldman, Matthew J. Maurer, Grzegorz S. Nowakowski, Brian K. Link, Thomas M. Habermann, Nicholas Stong, C. Chris Huang, Anita K. Gandhi, Susan L. Slager, Anne J. Novak, James R. Cerhan
Journal: Blood
Blood (2023) 142 (Supplement 1): 1633.
https://doi.org/10.1182/blood-2023-182291
Published: 2023